GHRL and metabolic dysfunction-associated steatohepatitis: Interestingly, a screening of miRNAs expression in visceral adipose tissue of NAFLD patients revealed that miR-132, of which the ghrelin gene is a predicted target, is downregulated in nonalcoholic steatohepatitis (NASH) compared to non-NASH patients [68], although a biological validation of this relationship still needs to be performed.